Publikationen in Zusammenarbeit mit Forschern von Mount Vernon Hospital (2)

2022

  1. First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

    British Journal of Cancer, Vol. 126, Núm. 11, pp. 1548-1554

2020

  1. Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

    Annals of Oncology, Vol. 31, Núm. 9, pp. 1160-1168